Whakatane 15 433 3.5 Gisborne 6 525 1.1 Hawke’s Bay 29 1,345 2.2 Taranaki Base 12 976 1.2 Palmerston North 17 1,288 1.3 Whanganui 12 568 2.1 Wellington 55 2,198 2.5 Hutt 41 1,285 3.2 Wairarapa 3 274 1.1 Wairau 8 315 2.5 Nelson 6 564 1.1 Grey Base 2 152 1.3 Christchurch 88 3,488 2.5 Timaru 4 450 0.9 Dunedin 21 1,181 1.8 Southland 10 822 1.2 All secondary and tertiary facilities 802 35,539 2.3 All primary facilities 65 5,756 1.1 All home births 14 2,150 0.7 New Zealand1 891 44,085 2.0 1 Includes women where birth location was unspecified. Indicators 13 to 15: Severe maternal morbidity Rationale and purpose Maternal mortality has long been monitored as an indicator of maternity system safety and quality. However, the number of maternal deaths in any given year is low. Impact of severe morbidity is significant and long term, of high personal cost to a woman and her family and of high financial cost to the health system. Monitoring severe morbidity allows a view of a larger, but still limited, set of cases that might provide a broader picture of the true impact of adverse outcomes in maternity in New Zealand and allow individual units to benchmark whether their rates of severe morbidity are consistent with those in other units. Cases of severe maternal morbidity should be subject to local multidisciplinary review for quality improvement purposes.
Whakatane 15 433 3.5 Gisborne 6 525 1.1 Hawke’s Bay 29 1,345 2.2 Taranaki Base 12 976 1.2 Palmerston North 17 1,288 1.3 Whanganui 12 568 2.1 Wellington 55 2,198 2.5 Hutt 41 1,285 3.2 Wairarapa 3 274 1.1 Wairau 8 315 2.5 Nelson 6 564 1.1 Grey Base 2 152 1.3 Christchurch 88 3,488 2.5 Timaru 4 450 0.9 Dunedin 21 1,181 1.8 Southland 10 822 1.2 All secondary and tertiary facilities 802 35,539 2.3 All primary facilities 65 5,756 1.1 All home births 14 2,150 0.7 New Zealand1 891 44,085 2.0 1 Includes women where birth location was unspecified. Indicators 13 to 15: Severe maternal morbidity Rationale and purpose Maternal mortality has long been monitored as an indicator of maternity system safety and quality. However, the number of maternal deaths in any given year is low. Impact of severe morbidity is significant and long term, of high personal cost to a woman and her family and of high financial cost to the health system. Monitoring severe morbidity allows a view of a larger, but still limited, set of cases that might provide a broader picture of the true impact of adverse outcomes in maternity in New Zealand and allow individual units to benchmark whether their rates of severe morbidity are consistent with those in other units. Cases of severe maternal morbidity should be subject to local multidisciplinary review for quality improvement purposes.
new-zealand-maternity-clinical-indicators-2015-dec16-v3.docx